The National Institutes of Health (NIH) has canceled over $8 billion in grants for long COVID research, a move that has left many in the medical community stunned. The federal office responsible for overseeing the research has been shuttered, and clinics that specialized in treating long COVID patients are closing their doors.
The Long COVID Crisis
The NIH has been a key player in the fight against long COVID, which affects over 44 million Americans who have reported lingering symptoms of the virus. Despite the massive number of people affected, headlines about long COVID have become increasingly rare in recent years.
One reason for the lack of attention is that the Biden administration has shifted its focus to other health issues. A spokesperson for the Department of Health and Human Services (HHS) said that the administration is prioritizing other pressing health concerns, including the opioid epidemic and mental health.
What’s Happening to Long COVID Research?
The canceled grants and shuttered office are just the beginning of the problem. Many researchers who were working on long COVID projects are now left without funding or support. This has resulted in a brain drain, as talented scientists and clinicians are forced to seek employment elsewhere.
The clinics that specialized in treating long COVID patients are also closing their doors. These clinics were often staffed by experienced healthcare professionals who had dedicated themselves to understanding and treating the condition. Without funding or support, it’s become impossible for these clinics to stay afloat.
A Crisis Disappearing from View
The cancellation of long COVID research grants and the closure of clinics are a stark reminder that the crisis is far from over. Despite the best efforts of healthcare workers and researchers, many people are still suffering from the lingering effects of COVID-19.
What this means: The cancellation of long COVID research grants and the closure of clinics will have a devastating impact on the millions of Americans who are still struggling with the effects of COVID-19. It’s essential for policymakers to recognize the severity of the crisis and allocate necessary resources to support research and treatment.
